tiprankstipranks
JW Therapeutics Announces Board Appointment
Company Announcements

JW Therapeutics Announces Board Appointment

JW (Cayman) Therapeutics Co. Ltd. (HK:2126) has released an update.

Don't Miss our Black Friday Offers:

JW (Cayman) Therapeutics Co. Ltd. has appointed Mr. Peng Kuan Chan as a new independent non-executive Director, effective August 28, 2024. With over 30 years of experience in finance and banking, Mr. Chan brings a wealth of knowledge to the board, having held multiple directorships and senior roles in various listed companies. His appointment is part of a broader change in the composition of the company’s board committees.

For further insights into HK:2126 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskJW Cayman Therapeutics Appoints Deloitte as New Auditor
TipRanks HongKong Auto-Generated NewsdeskJW Therapeutics Announces New Share Grants
TipRanks HongKong Auto-Generated NewsdeskJW Therapeutics Announces Board Structure
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App